Pharmaceutical Statistics

Papers
(The H4-Index of Pharmaceutical Statistics is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
An illness–death multistate model to implement delta adjustment and reference‐based imputation with time‐to‐event endpoints960115767
Conditional power and information fraction calculations at an interim analysis for random coefficient models876022323
Propensity score‐incorporated adaptive design approaches when incorporating real‐world data858791986
Issue Information842074418
Probability of success and group sequential designs758329376
Assessing the quality of studies in meta‐research: Review/guidelines on the most important quality assessment tools59
To use or not to use propensity score matching?51
Principal stratum strategy: Potential role in drug development33
The use of external controls: To what extent can it currently be recommended?31
Controlling type I error rates in multi‐arm clinical trials: A case for the false discovery rate21
A Bayesian approach in design and analysis of pediatric cancer clinical trials20
The attributable estimand: A new approach to account for intercurrent events18
Adjusting win statistics for dependent censoring18
Joint hypothesis testing of the area under the receiver operating characteristic curve and the Youden index18
Comparison of response adaptive randomization features in multiarm clinical trials with control16
Win statistics (win ratio, win odds, and net benefit) can complement one another to show the strength of the treatment effect on time‐to‐event outcomes16
How to choose a time zero for patients in external control arms16
0.04651403427124